NMC Health (LSE:NMC)
NMC Health is the largest health-care provider in the United Arab Emirates and the second-largest provider of in-vitro fertilization in the world.
{{ formattedPrice }} {{ change }} (-6.12%)
Quotes delayed. Last trade: 22-03-2019, 04:36:38pm GMT
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 581199 |
Related Articles
-
This could be the FTSE 100’s most rampant growth share, and it’s on sale!
The outlook is bullish. Yet you can pick up a few of this fast-growing FTSE 100 (INDEXFTSE: UKX) company’s shares on a forward-looking price-to-earnings... Read More »
-
Have £3,000 to spend? I think these 3 FTSE 100 stocks are far, far too cheap!
Royston Wild discusses a trio of FTSE 100 (INDEXFTSE: UKX) shares trading much too cheaply at the present time. Read More »
-
Don’t know where to start investing? Here’s how I’d invest £5,000 today
Rupert Hargreaves outlines how he'd invest £5,000 today to get the most out of his money. Read More »
-
Forget the top cash ISA rate! I’d much rather buy this FTSE 100 growth stock
This FTSE 100 (INDEXFTSE: UKX) is a much better investment choice than stashing your investment funds in a cash ISA, argues Royston Wild. Read More »
-
Why Rolls-Royce Holding is a FTSE 100 growth stock I’d buy today
Rolls-Royce Holding plc (LON: RR) could outperform the FTSE 100 (INDEXFTSE: UKX). Read More »
-
Why I might buy Smith & Nephew shares after a 6% price surge
A Q3 update sent the Smith & Nephew plc (LSE: SN) share price flying, but I believe there's more to come. Read More »
-
A FTSE 100 dividend growth stock I’d buy and hold all the way through to 2030
Royston Wild pores over an exceptional FTSE 100 (INDEXFTSE: UKX) dividend stock. Read More »
-
Why FTSE 100 growth stock NMC Health could trash the GSK share price
Roland Head compares the outlook for FTSE 100 (INDEXFTSE:UKX) healthcare stocks NMC Health plc (LON:NMC) and GlaxoSmithKline plc (LON:GSK). Read More »
-
Why I think it’s time to buy this FTSE 100 stock, down 25% in two months
Rupert Hargreaves discusses the valuation and prospects of a fallen FTSE 100 (INDEXFTSE: UKX) flyer and a savaged mid-cap with a trading update out... Read More »
-
FTSE 100 dividend stock GlaxoSmithKline isn’t the only healthcare star that could help you retire rich
Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is just one London-quoted healthcare stock that could make you rich. Read More »
